- Home
- VOD vs ZTS Comparison
VOD vs ZTS Comparison
Compare VOD & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VOD | ZTS |
|---|---|---|
| Founded | 1984 | 1952 |
| Country | United Kingdom | United States |
| Employees | 86702 | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.7B | 31.2B |
| IPO Year | N/A | 2012 |
Fundamental Metrics
Financial Performance| Metric | VOD | ZTS |
|---|---|---|
| Price | $14.69 | $79.63 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 3 | 12 |
| Target Price | N/A | ★ $154.18 |
| AVG Volume (30 Days) | 3.1M | ★ 9.2M |
| Earning Date | 06-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.24% | 1.86% |
| EPS Growth | N/A | ★ 10.05 |
| EPS | N/A | ★ 1.42 |
| Revenue | N/A | ★ $9,467,000,000.00 |
| Revenue This Year | $11.47 | $5.63 |
| Revenue Next Year | $5.90 | $4.77 |
| P/E Ratio | ★ N/A | $55.99 |
| Revenue Growth | N/A | ★ 2.28 |
| 52 Week Low | $10.03 | $73.82 |
| 52 Week High | $16.61 | $169.50 |
Technical Indicators
Market Signals| Indicator | VOD | ZTS |
|---|---|---|
| Relative Strength Index (RSI) | 40.49 | 33.83 |
| Support Level | $14.64 | $73.82 |
| Resistance Level | $14.81 | $82.34 |
| Average True Range (ATR) | 0.18 | 2.54 |
| MACD | -0.02 | 1.44 |
| Stochastic Oscillator | 4.73 | 66.71 |
Price Performance
Historical ComparisonAbout VOD Vodafone Group Plc
Vodafone operates mobile and fixed-line networks and businesses across Europe, Africa, and the Middle East. Its largest market is Germany, where it is the second mobile operator after Deutsche Telekom and owns two cable networks after acquiring Kabel Deutschland in 2013 and Liberty Global Germany in 2019. In the UK, Vodafone merged with CK Hutchison in 2024, consolidating the mobile market. It also divested its Spanish and Italian divisions in that same year, given their low returns on invested capital.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.